Genmab A/S (CPH:GMAB)
Denmark flag Denmark · Delayed Price · Currency is DKK
2,156.00
-11.00 (-0.51%)
Aug 28, 2026, 4:59 PM CET

Genmab Revenue

Genmab had revenue of $1.16B USD in the quarter ending June 30, 2026, with 24.86% growth. This brings the company's revenue in the last twelve months to $4.13B, up 28.86% year-over-year. In the year 2025, Genmab had annual revenue of $3.72B with 19.19% growth.

Revenue (ttm)
$4.13B
Revenue Growth
+28.86%
P/S Ratio
4.76
Revenue / Employee
$1.32M
Employees
3,119
Market Cap
128.72B DKK

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.72B599.00M19.19%
Dec 31, 20243.12B731.00M30.59%
Dec 31, 20232.39B302.26M14.48%
Dec 31, 20222.09B800.56M62.19%
Dec 31, 20211.29B-372.56M-22.45%
Dec 31, 20201.66B854.43M106.10%
Dec 31, 2019805.32M340.75M73.35%
Dec 31, 2018464.57M83.44M21.89%
Dec 31, 2017381.13M123.38M47.87%
Dec 31, 2016257.75M92.65M56.12%
Dec 31, 2015165.10M26.80M19.38%
Dec 31, 2014138.30M15.94M13.02%
Dec 31, 2013122.37M36.66M42.78%
Dec 31, 201285.70M24.59M40.23%
Dec 31, 201161.12M-43.27M-41.45%
Dec 31, 2010104.39M-8.77M-7.75%
Dec 31, 2009113.16M-16.25M-12.56%
Dec 31, 2008129.42M25.30M24.29%
Dec 31, 2007104.12M80.20M335.29%
Dec 31, 200623.92M8.33M53.41%
Dec 31, 200515.59M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Novo Nordisk329.43B
Coloplast28.44B
H. Lundbeck25.96B
Demant24.63B
GN Store Nord16.46B
ALK-Abelló6.83B
Embla Medical6.44B
Bavarian Nordic6.34B
Revenue Rankings